Cite
HARVARD Citation
Hanauer, S. et al. (2021). Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial. Lancet gastroenterology and hepatology. pp. 816-825. [Online].